Skip to main content
. 2013 Aug 26;4:102. doi: 10.3389/fphar.2013.00102

Figure 9.

Figure 9

Cognitive composite z-scores in double-blind 6-week acute phase study of lurasidone (LUR) relative to placebo (PBO). Data are based on LOCF analysis of CogState composite score (standardized z-score) at week 6 in the evaluable-test sample set (N = 267). *P < 0.05, ANCOVA adjusted for baseline and pooled center.